Rare diseases
Investigational molecules
Locations
Back to Italy621 clinical trials in Meldola, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Giredestrant for Patients with Grade 1 Endometrial Cancer
ItalyStudy on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma
ItalyStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
ItalyStudy on TTX-030, Budigalimab, and Chemotherapy for Untreated Metastatic Pancreatic Cancer Patients
ItalyStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
ItalyStudy Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ItalyStudy on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma
ItalyStudy of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy
ItalyStudy of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma
ItalyStudy of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer
ItalyStudy Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ItalyStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on blood cancers, including studies of novel therapeutic combinations for acute myeloid leukemia, multiple myeloma, and various lymphomas.
Studies are evaluating targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into advanced solid tumors, with particular emphasis on colorectal cancer, non-small cell lung cancer, and breast cancer.
Investigations focus on personalized treatment strategies and novel drug combinations.
Groundbreaking studies in urological cancers, including research on prostate cancer, urothelial cancer, and renal cell carcinoma.
Research aims to improve survival rates through innovative therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
